Many of us still envision former Nationals' third and first baseman Ryan Zimmerman with a curly W on this cap winning the ...

In a report released today, Ryan Zimmerman from BTIG maintained a Buy rating on Zimmer Biomet Holdings (ZBH – Research Report), with a price ...

Ryan Zimmerman is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth ...

BTIG analyst Ryan Zimmerman upgraded Treace Medical (TMCI) to Buy from Neutral with a $16 price target The company has pivoted away from ...

This story was excerpted from the Nationals Beat newsletter, with MLB.com reporter Bill Ladson filling in for beat reporter Jessica Camerato this week. To read the full newsletter, click here. And ...